4//SEC Filing
MCLAUGHLIN KEVIN F 4
Accession 0001140361-25-004765
CIK 0000887359other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:05 PM ET
Size
13.6 KB
Accession
0001140361-25-004765
Insider Transaction Report
Form 4
Vericel CorpVCEL
MCLAUGHLIN KEVIN F
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-12$2.76/sh+1,000$2,760→ 12,900 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-12+1,000→ 14,000 totalExercise: $2.76Exp: 2026-05-04→ Common Stock (1,000 underlying) - Exercise/Conversion
Common Stock
2025-02-12$3.74/sh+6,000$22,440→ 17,900 total - Sale
Common Stock
2025-02-12$55.47/sh−6,000$332,820→ 11,900 total - Sale
Common Stock
2025-02-12$55.43/sh−1,000$55,430→ 11,900 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-12+6,000→ 0 totalExercise: $3.74→ Common Stock (6,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
- [F2]These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.
- [F3]These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025
- [F4]These options, representing the right to purchase a total of 15,000 shares, were originally granted on May 4, 2016, and became exercisable in equal monthly installments over the course of one year, contingent upon continued service to the Company.
Documents
Issuer
Vericel Corp
CIK 0000887359
Entity typeother
Related Parties
1- filerCIK 0001214938
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:05 PM ET
- Size
- 13.6 KB